XML 27 R17.htm IDEA: XBRL DOCUMENT
v3.25.1

Business and Geographical Reporting Segments | 3 Months Ended
--- | ---
Mar. 31, 2025
Business and Geographical Reporting Segments [Abstract] |
Business and Geographical Reporting Segments | Note 11 Business and Geographical Reporting Segments: The Company has organized its business into two operating segments to better align its organization based upon the Company’s management structure, products and services offered, markets served and types of customers. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC and TheraClear procedures. The Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. The Company’s chief operating decision maker (“CODM”) is the chief executive officer. The CODM reviews financial information presented on an operating segment basis for the purposes of making certain operating decisions and assessing financial performance. Unallocated operating expenses include costs that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses. Interest and other financing income (expense) is also not allocated to the operating segments. The following tables present results of operations from the Company’s business segments for the periods indicated below (in thousands, except gross profit %):
Three Months Ended March 31, 2025 |  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | Total |
Revenues, net |  | $ | 4,727 |  |  | $ | 2,085 |  |  | $ | 6,812 |
Cost of revenues |  |  | 2,049 |  |  |  | 1,116 |  |  |  | 3,165 |
Gross profit |  |  | 2,678 |  |  |  | 969 |  |  |  | 3,647 |
Gross profit % |  |  | 56.7 | % |  |  | 46.5 | % |  |  | 53.5 | %
Allocated expenses: |  |  |  |  |  |  |  |  |  |  |  |
Engineering and product development |  |  | 66 |  |  |  | 30 |  |  |  | 96 |
Selling and marketing |  |  | 2,077 |  |  |  | 916 |  |  |  | 2,993 |
Unallocated expenses |  |  | — |  |  |  | — |  |  |  | 2,573 |
Total allocated and unallocated expenses |  |  | 2,143 |  |  |  | 946 |  |  |  | 5,662 |
Income (loss) from operations |  |  | 535 |  |  |  | 23 |  |  |  | (2,015 | )
Interest expense |  |  | — |  |  |  | — |  |  |  | (486 | )
Interest income |  |  | — |  |  |  | — |  |  |  | 69 |
Net income (loss) |  | $ | 535 |  |  | $ | 23 |  |  | $ | (2,432 | )
Three Months Ended March 31, 2024 |  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | Total |
Revenues, net |  | $ | 4,696 |  |  | $ | 2,058 |  |  | $ | 6,754 |
Cost of revenues |  |  | 2,195 |  |  |  | 1,479 |  |  |  | 3,674 |
Gross profit |  |  | 2,501 |  |  |  | 579 |  |  |  | 3,080 |
Gross profit % |  |  | 53.3 | % |  |  | 28.1 | % |  |  | 45.6 | %
Allocated expenses: |  |  |  |  |  |  |  |  |  |  |  |
Engineering and product development |  |  | 196 |  |  |  | 45 |  |  |  | 241 |
Selling and marketing |  |  | 2,753 |  |  |  | 265 |  |  |  | 3,018 |
Unallocated expenses |  |  | — |  |  |  | — |  |  |  | 2,710 |
Total allocated and unallocated expenses |  |  | 2,949 |  |  |  | 310 |  |  |  | 5,969 |
(Loss) income from operations |  |  | (448 | ) |  |  | 269 |  |  |  | (2,889 | )
Interest expense |  |  | — |  |  |  | — |  |  |  | (524 | )
Interest income |  |  | — |  |  |  | — |  |  |  | 45 |
Net (loss) income |  | $ | (448 | ) |  | $ | 269 |  |  | $ | (3,368 | )
The following table presents depreciation and amortization by reportable segment for the periods indicated below (in thousands):
|  | Three Months Ended March 31, |
|  | 2025 |  |  | 2024 |
Dermatology recurring procedures |  | $ | 1,120 |  |  | $ | 1,114 |
Dermatology procedures equipment |  |  | 100 |  |  |  | 132 |
Unallocated expenses |  |  | — |  |  |  | 3 |
Total |  | $ | 1,220 |  |  | $ | 1,249 |
The following tables present the Company’s revenue disaggregated by geographical region for the periods indicated below (in thousands). Domestic refers to revenue from customers based in the United States, and foreign revenue is derived from the Company’s distributors primarily in Asia.
Three Months Ended March 31, 2025 |  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | Total |
Domestic |  | $ | 4,248 |  |  | $ | 149 |  |  | $ | 4,397 |
China |  |  | — |  |  |  | 834 |  |  |  | 834 |
Middle East |  |  | — |  |  |  | 711 |  |  |  | 711 |
Other foreign |  |  | 479 |  |  |  | 391 |  |  |  | 870 |
Total |  | $ | 4,727 |  |  | $ | 2,085 |  |  | $ | 6,812 |
Three Months Ended March 31, 2024 |  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | Total |
Domestic |  | $ | 4,320 |  |  | $ | 141 |  |  | $ | 4,461 |
China |  |  | — |  |  |  | 1,102 |  |  |  | 1,102 |
Middle East |  |  | — |  |  |  | 430 |  |  |  | 430 |
Other foreign |  |  | 376 |  |  |  | 385 |  |  |  | 761 |
Total |  | $ | 4,696 |  |  | $ | 2,058 |  |  | $ | 6,754 |
The following table presents total assets by reportable segment (in thousands):
|  | March 31, 2025 |  |  | December 31, 2024 |
Dermatology recurring procedures |  | $ | 20,071 |  |  | $ | 21,750 |
Dermatology procedures equipment |  |  | 5,798 |  |  |  | 5,081 |
Other unallocated assets |  |  | 8,393 |  |  |  | 9,326 |
Total |  | $ | 34,262 |  |  | $ | 36,157 |
Long-lived assets of $1.2 million and $1.3 million were located in international markets, primarily Korea and Japan, as of March 31, 2025 and December 31, 2024, respectively, with the remainder located in domestic markets.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 9: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration